Arcutis BiotherapeuticsARQT
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 239 institutions reported holding Arcutis Biotherapeutics Inc. (ARQT) in their 13F filings, up 9 from Q2 2025. 33 opened new positions and 20 sold out. The largest holders were Jennison Associates LLC ($231.0M), Rubric Capital Management LP ($202.6M) and Montanova Capital, LLC ($197.5M). 5 famous investors held it, including David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio), Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio) and Cliff Asness (0.0% of AQR Capital Management's portfolio).
- Company
- Arcutis Biotherapeutics Inc.
- CUSIP
- 03969K108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 33 | $33.5M |
| Exits | 20 | $31.6M |
All 13F filers, Q2 2025 → Q3 2025: 8,961,282 shares bought and 10,034,293 shares sold, net −1,073,011 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 239 holders
| Jennison Associates LLC | 0.13% | Add +10.3% | 12,254,119 | $231.0M |
| Rubric Capital Management LP | 2.72% | No change | 10,749,457 | $202.6M |
| Montanova Capital, LLC | 5.99% | Reduce -9.2% | 10,478,000 | $197.5M |
| Frazier Life Sciences Management, L.P. | 5.59% | No change | 9,874,511 | $186.1M |
| BlackRock, Inc. | 0.00% | Add +0.5% | 8,573,995 | $161.6M |
| Vanguard Group Inc. | 0.00% | Add +1.4% | 7,146,090 | $134.7M |
| Polar Capital Holdings Plc | 0.48% | Add +5.8% | 5,298,754 | $99.9M |
| State Street Corp. | 0.00% | Add +2.5% | 4,641,315 | $87.5M |
| Gilder Gagnon Howe & Co. LLC | 0.85% | Add +6.6% | 4,429,108 | $83.5M |
| Morgan Stanley | 0.00% | Reduce -0.9% | 4,276,394 | $80.6M |
| UBS Group AG | 0.01% | Add +0.4% | 2,948,438 | $55.6M |
| Geode Capital Management, LLC | 0.00% | Add +0.9% | 2,606,465 | $49.1M |
| Janus Henderson Group PLC | 0.02% | Add +5.9% | 2,398,031 | $45.2M |
| Franklin Resources Inc. | 0.01% | Reduce -15.4% | 2,311,019 | $43.6M |
| Pivotal bioVenture Partners Investment Advisor LLC | 23.11% | No change | 2,120,508 | $40.0M |
| D. E. Shaw & Co. | 0.03% | Reduce -2.0% | 2,118,713 | $39.9M |
| Perpetual Ltd | 0.47% | Add +7534.3% | 2,024,606 | $38.2M |
| Ensign Peak Advisors, Inc | 0.06% | Reduce -0.4% | 1,993,055 | $37.6M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -4.5% | 1,804,988 | $34.0M |
| American Century Companies Inc. | 0.02% | Reduce -3.6% | 1,662,470 | $31.3M |
| Nuveen, LLC | 0.01% | Add +79.0% | 1,370,356 | $25.8M |
| GW&K Investment Management, LLC | 0.20% | Reduce -15.0% | 1,172,041 | $22.1M |
| Driehaus Capital Management LLC | 0.15% | Add +1.0% | 1,097,004 | $20.7M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +3.6% | 999,434 | $18.8M |
| Northern Trust Corp. | 0.00% | Add +1.2% | 940,202 | $17.7M |
| Bank of America Corp. | 0.00% | Reduce -26.1% | 889,285 | $16.8M |
| Voloridge Investment Management, LLC | 0.05% | New | 833,490 | $15.7M |
| Qube Research & Technologies Ltd | 0.02% | Add +41.0% | 814,567 | $15.4M |
| Candriam S.C.A. | 0.08% | Reduce -1.6% | 778,044 | $14.7M |
| Cormorant Asset Management, LP | 1.01% | Reduce -22.5% | 775,000 | $14.6M |
| Federated Hermes, Inc. | 0.03% | Add +3.0% | 759,573 | $14.3M |
| Aberdeen Group plc | 0.02% | No change | 675,034 | $12.7M |
| Jupiter Asset Management Ltd. | 0.11% | Add +59.8% | 659,331 | $12.4M |
| Fishman Jay A Ltd. | 0.91% | Add +1.7% | 565,650 | $10.7M |
| Tejara Capital Ltd | 5.38% | Reduce -40.4% | 520,503 | $9.8M |
| MYDA Advisors LLC | 2.68% | Add +27.0% | 470,000 | $8.9M |
| AQR Capital Management | 0.01% | Add +17.6% | 441,315 | $8.3M |
| Stempoint Capital LP | 1.57% | Add +100.3% | 411,893 | $7.8M |
| Deutsche Bank AG | 0.00% | Add +2.8% | 377,528 | $7.1M |
| Jane Street Group, LLC | 0.01% | Add +183.8% | 360,770 | $6.8M |
| PFM Health Sciences, LP | 0.59% | Reduce -61.0% | 360,460 | $6.8M |
| J. Goldman & Co LP | 0.25% | Reduce -58.9% | 353,644 | $6.7M |
| Jump Financial, LLC | 0.09% | Add +2306.8% | 350,485 | $6.6M |
| Barclays PLC | 0.00% | Reduce -17.3% | 325,968 | $6.1M |
| Simplify Asset Management Inc. | 0.12% | Reduce -22.3% | 317,997 | $6.0M |
| Woodline Partners LP | 0.03% | Add +53.1% | 314,619 | $5.9M |
| Bank of New York Mellon Corp | 0.00% | Add +1.8% | 310,620 | $5.9M |
| Privium Fund Management B.V. | 1.04% | Reduce -11.2% | 305,972 | $5.8M |
| Lazard Asset Management LLC | 0.01% | Reduce -27.6% | 279,619 | $5.3M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Reduce -39.7% | 244,015 | $4.6M |
| Ally Bridge Group (NY) LLC | 3.68% | New | 233,220 | $4.4M |
| Algert Global LLC | 0.07% | Add +132.3% | 229,392 | $4.3M |
| First Trust Advisors LP | 0.00% | Reduce -34.1% | 224,965 | $4.2M |
| Avidity Partners Management LP | 0.92% | Reduce -20.0% | 214,400 | $4.0M |
| Swiss National Bank | 0.00% | Add +1.9% | 207,900 | $3.9M |
| Vestal Point Capital, LP | 0.17% | Add +110.5% | 200,000 | $3.8M |
| Essex Investment Management Co. LLC | 0.57% | Add +3.6% | 196,262 | $3.7M |
| Invesco Ltd. | 0.00% | Add +93.5% | 192,952 | $3.6M |
| Schonfeld Strategic Advisors LLC | 0.03% | Reduce -63.6% | 189,555 | $3.6M |
| Royal Bank of Canada | 0.00% | Reduce -28.6% | 188,280 | $3.5M |
| Rhumbline Advisers | 0.00% | Reduce -1.6% | 183,129 | $3.5M |
| Citadel Advisors | 0.00% | Add +21.8% | 177,268 | $3.3M |
| FMR LLC | 0.00% | Add +11.4% | 167,974 | $3.2M |
| Squarepoint Ops LLC | 0.01% | Reduce -4.8% | 159,847 | $3.0M |
| PDT Partners, LLC | 0.18% | Reduce -19.3% | 154,108 | $2.9M |
| Millennium Management | 0.00% | Reduce -83.5% | 150,099 | $2.8M |
| Rafferty Asset Management, LLC | 0.01% | Reduce -3.9% | 148,295 | $2.8M |
| Jackson Creek Investment Advisors LLC | 0.74% | Reduce -0.0% | 135,819 | $2.6M |
| State of Wisconsin Investment Board | 0.01% | Add +37.9% | 123,961 | $2.3M |
| LPL Financial LLC | 0.00% | Reduce -3.9% | 116,924 | $2.2M |
| Alliancebernstein L.P. | 0.00% | No change | 113,360 | $2.1M |
| Eversept Partners, LP | 0.16% | New | 111,466 | $2.1M |
| Legal & General Group Plc | 0.00% | Reduce -1.9% | 109,444 | $2.1M |
| Phocas Financial Corp. | 0.26% | Add +2.2% | 106,307 | $2.0M |
| Wells Fargo & Company | 0.00% | Reduce -46.4% | 105,257 | $2.0M |
| California State Teachers Retirement System | 0.00% | Add +6.8% | 104,340 | $2.0M |
| JPMorgan Chase & Co. | 0.00% | Reduce -81.6% | 100,794 | $1.9M |
| Ameriprise Financial Inc. | 0.00% | Add +0.1% | 99,185 | $1.9M |
| Ami Asset Management Corp. | 0.10% | Reduce -15.6% | 96,091 | $1.8M |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +44.4% | 95,625 | $1.8M |
| Two Sigma Investments, LP | 0.00% | Add +33.1% | 95,429 | $1.8M |
| T. Rowe Price Associates Inc. | 0.00% | Add +4.5% | 87,802 | $1.7M |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0.00% | New | 86,485 | $1.6M |
| Stifel Financial Corp. | 0.00% | Reduce -11.5% | 79,805 | $1.5M |
| DekaBank Deutsche Girozentrale | 0.00% | No change | 140,000 | $1.4M |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | Add +157.7% | 76,181 | $1.4M |
| Erste Asset Management GmbH | 0.01% | No change | 73,100 | $1.4M |
| Wesbanco Bank Inc. | 0.04% | Reduce -30.2% | 71,700 | $1.4M |
| Tudor Investment Corporation | 0.01% | New | 69,980 | $1.3M |
| Cubist Systematic Strategies, LLC | 0.02% | New | 66,080 | $1.2M |
| Victory Capital Management Inc. | 0.00% | Add +107.3% | 66,044 | $1.2M |
| Focus Partners Wealth | 0.00% | Add +0.8% | 65,196 | $1.2M |
| Susquehanna International Group, LLP | 0.00% | Reduce -74.9% | 65,596 | $1.2M |
| MetLife Investment Management, LLC | 0.01% | No change | 64,485 | $1.2M |
| Los Angeles Capital Management LLC | 0.00% | Add +104.2% | 63,025 | $1.2M |
| Raymond James Financial Inc. | 0.00% | Add +12.0% | 60,074 | $1.1M |
| Legato Capital Management LLC | 0.12% | No change | 56,717 | $1.1M |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -3.3% | 56,023 | $1.1M |
| Schroder Investment Management Group | 0.00% | New | 56,542 | $1.1M |
| Intech Investment Management LLC | 0.01% | Reduce -41.3% | 50,610 | $954K |
"% of holder's portfolio" is ARQT's weight in each manager's 13F, not the share of Arcutis Biotherapeutics Inc. the manager owns.